ArticleDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2014
Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market.
Article in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Medication supply chain resilience during disasters: exploration of causes, strategies, and consequences applying Strauss and Corbin's approach to the grounded theory.Journal of pharmaceutical policy and practice · 2023Article
- The Role of Desorptive Capacity in the Relationship of Entrepreneurial Orientation - Open Innovation Performance: The Case of the Pharmaceutical Industry.Iranian journal of pharmaceutical research : IJPR · 2021Article
- The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016.Journal of pharmaceutical policy and practice · 2020Article
- Article
- Determinants of Iran'sIranian journal of pharmaceutical research : IJPR · 2018Article
- Article
- A Study of Comparative Advantage and Intra-Industry Trade in the Pharmaceutical Industry of Iran.Global journal of health science · 2015Article
- Assessing the Factors Associated With Iran's Intra-Industry Trade in Pharmaceuticals.Global journal of health science · 2015Article
- Trend Analysis of Medicine Consumption Based on Therapeutic Categories in Iran: 2000-2016.Journal of research in pharmacy practiceArticle
- Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors.Journal of research in pharmacy practiceArticle
- Assessment of the Effects of Corporate Governance on the Competitiveness of Pharmaceutical Companies Through Improved Total Factor Productivity.Iranian journal of pharmaceutical research : IJPRArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPharmaceutical industry is knowledge-intensive and highly globalized, in both developed and developing countries. On the other hand, if companies want to survive, they should be able to compete well in both domestic and international markets. The main purpose of this paper is therefore to develop and prioritize key factors affecting companies' competitiveness in pharmaceutical industry. Based on an extensive literature review, a valid and reliable questionnaire was designed, which was later filled up by participants from the industry. To prioritize the key factors, we used the Technique for Order Preference by Similarity to Ideal Solution (TOPSIS).
resultsThe results revealed that human capital and macro-level policies were two key factors placed at the highest rank in respect of their effects on the competitiveness considering the industry-level in pharmaceutical area.
conclusionThis study provides fundamental evidence for policymakers and managers in pharma context to enable them formulating better polices to be proactively competitive and responsive to the markets' needs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.